# STOCKHOLM 1.0
#=GF ID   TylF
#=GF AC   PF05711.15
#=GF DE   Macrocin-O-methyltransferase (TylF)
#=GF AU   Moxon SJ;0000-0003-4644-1816
#=GF SE   Pfam-B_5055 (release 8.0)
#=GF GA   23.00 23.00;
#=GF TC   23.00 23.00;
#=GF NC   22.90 22.90;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch -Z 75585367 -E 1000 --cpu 4 HMM pfamseq
#=GF TP   Domain
#=GF CL   CL0063
#=GF RN   [1]
#=GF RM   10220165
#=GF RT   The tylosin biosynthetic cluster from Streptomyces fradiae:
#=GF RT   genetic organization of the left region. 
#=GF RA   Fouces R, Mellado E, Diez B, Barredo JL; 
#=GF RL   Microbiology 1999;145:855-868.
#=GF RN   [2]
#=GF RM   19857499
#=GF RT   The crystal structure of the novobiocin biosynthetic enzyme
#=GF RT   NovP: the first representative structure for the TylF
#=GF RT   O-methyltransferase superfamily.
#=GF RA   Gomez Garcia I, Stevenson CE, Uson I, Freel Meyers CL, Walsh CT,
#=GF RA   Lawson DM;
#=GF RL   J Mol Biol. 2010;395:390-407.
#=GF DR   INTERPRO; IPR008884;
#=GF DR   SO; 0000417; polypeptide_domain;
#=GF CC   This family consists of bacterial macrocin O-methyltransferase
#=GF CC   (TylF) proteins. TylF is responsible for the methylation of
#=GF CC   macrocin to produce tylosin. Tylosin is a macrolide antibiotic
#=GF CC   used in veterinary medicine to treat infections caused by
#=GF CC   Gram-positive bacteria and as an animal growth promoter in the
#=GF CC   swine industry. It is produced by several Streptomyces species.
#=GF CC   As with other macrolides, the antibiotic activity of tylosin is
#=GF CC   due to the inhibition of protein biosynthesis by a mechanism
#=GF CC   that involves the binding of tylosin to the ribosome, preventing
#=GF CC   the formation of the mRNA-aminoacyl-tRNA-ribosome complex [1].
#=GF CC   The structure of one representative sequence from this family,
#=GF CC   NovP, shows it to be an S-adenosyl-l-methionine-dependent
#=GF CC   O-methyltransferase that catalyses the penultimate step in the
#=GF CC   biosynthesis of the aminocoumarin antibiotic novobiocin.
#=GF CC   Specifically, it methylates at 4-OH of the noviose moiety, and
#=GF CC   the resultant methoxy group is important for the potency of the
#=GF CC   mature antibiotic. It is likely that the key structural features
#=GF CC   of NovP are common to the rest of the family and include: a
#=GF CC   helical 'lid' region that gates access to the co-substrate
#=GF CC   binding pocket and an active centre that contains a 3-Asp
#=GF CC   putative metal binding site. A further conserved Asp probably
#=GF CC   acts as the general base that initiates the reaction by
#=GF CC   de-protonating the 4-OH group of the noviose unit [2].
#=GF SQ   12
#=GS E3IUK9_FRAIE/24-263   AC E3IUK9.1
#=GS V6JI83_STRNV/11-256   AC V6JI83.1
#=GS A9AYT1_HERA2/6-276    AC A9AYT1.1
#=GS A4F7H0_SACEN/22-268   AC A4F7H0.1
#=GS D5ALV4_RHOCB/319-590  AC D5ALV4.1
#=GS I3TT02_TISMK/4-274    AC I3TT02.1
#=GS B7FWH7_PHATC/88-325   AC B7FWH7.1
#=GS D5SXC9_PLAL2/21-290   AC D5SXC9.1
#=GS Q2JDH4_FRACC/23-284   AC Q2JDH4.1
#=GS E3IYZ5_FRAIE/13-273   AC E3IYZ5.1
#=GS E3I1R4_RHOVT/29-268   AC E3I1R4.1
#=GS Q81GJ3_BACCR/7-280    AC Q81GJ3.1
E3IUK9_FRAIE/24-263              NEDYLDLMKRILTNTIYQD..................................PPVSRAEAAFDGDRRATGQDW......P..SVAHTMVGRARLDNVHACAATAITEGVPGDLVETGVWRGGTAIFMRAVLRAYGATDRLVWACDSFEGMPVSGPDSHPSDQ..........Q.TRLHLANA..VL.....AIPLEQVRANFDVYGLLDDQVRFLKGWFRDTLPTAPIERIAV..LRLDGDLYESTMDTLDSLYPKVSPGGFVIIDDYQI.PACREAVHDYRDAHGITAPLTRIDQWAVFWR.
V6JI83_STRNV/11-256              SSLYLDLMIKVLAGTVYED..............................PAHRENFSHRDSTYREEVRNEGRDW......P..ANAHTMIGIKRLENIRQCVEDVIGNNVPGDLVETGVWRGGACILMRGILRAHDVRDRTVWVADSFQGIPDVGEDGYAGDR..........K.MALHRRNS..VL.....AVSEDEVRRNFRNYDLLDEQVRFLPGWFKDTLPTAPIDTLAV..LRMDGDLYESTWDTLTNLYPKVSVGGYVIVDDYMMCPPCKDAVDEYRAKFDIADELITIDRDGVYWQR
A9AYT1_HERA2/6-276               AQLYLDLLKRCIMGLVYED....................QPLRNIVYEPFSINAPYTGPYSTFDREKRLNGHEW......P..SQAHTMLSMHRLNNIQSLVTDILEKQIPGDLIETGVWRGGATIFMRGILKAYNCNDRTVWVADSFQGFPKNEEEGLLGETESPGLPQEQHG.PPPKPIQD..ILDLLWKGTSYEDVRQHFEQYGLLDDQVKFLKGWFCHTLHQAPIDNLAL..LRLDGDLYDSTYDALEALYPKVSQGGYVIVDDYATFEECYNAVHDYLESIGAEVTMQPIDEDSVFWQK
A4F7H0_SACEN/22-268              GTRYLELMKRVLTNVVYED............................VTHRLDHANARGNPRFDPERRRNGLDW......P..SVAHTMIGRKRLDNLHDCLERVVADDVPGDLAETGVWRGGACIFMRAFLAAHGITDRQVWVADSFEGMPDTDGSAHDLDR..........E.LALHRMNE..VL.....GIPLEVVRDNFRRYGLLDEQVRFLPGWFADTLPAAPVSELAV..LRLDGDLYESTMDALVHLYPRLSPGGFVIVDDYAL.PPCRAAVREFRRDNGIHEPVEWIDYMGVYWRR
D5ALV4_RHOCB/319-590             GERYLDLLKAVLLNETGLE....TEVALDALRGRKDIPPAFWSETLYDVPGQLAPALAEKR....RLRAQGLDTLTAQAGP..PLGYTMIGRRRLDHLQDCVATVLAEAVPGDLMECGVWRGGACLLMKAMLDLAGAQDRSLWVADSFAGLPPP...ALPEDE..........GLDLSRERAP..AL.....AVSQARVERAFADFGLLDARVRFLPGFFADTLAGCAVEKLAL..LRLDGDLYSSTLQALEALYDRVAPGGFVIIDDYGALGQCALAVDRFRAARGITAPLGMIDWTGAFWRK
I3TT02_TISMK/4-274               TRLYLDLLKQVLLNQTGLEAELRLAHVAACHVAGTDPDPYHLRDIRFTEAETFAAAAARRD....DGRWTAADR......PGLGLAYTMTGRQRLDHLEACLDDIRTEGVPGDLIETGVWRGGCGIFMRGYLAVHAMADRRVWLADSFAGVPAP...SHAIDA..........G.DTLFQQND..LL.....AISRPLVEDAFRRFDLLDDRVRFVEGLFEETLPGLDTGPLAL..LRLDGDLFTSTCAALEALYDRVAPGGWIIIDDYGAVQGCRIATDMFRHVRGITTPLDRVDWTCVAWRK
B7FWH7_PHATC/88-325              ASEYLQTLTKVMVGTPLGG............................SYHNNHRQIGQTPFPFEERLRAVGEDW......P..PFGYTMIGKARMQNFRNAIEEVNQNGIPGAIVELGVWRGGAMI.MASALGKESGRIRDLYLFDTFAPI......................GTYGSKELTQ..YL.....AVPEDEVRESFRYFDLDGPFVHLEKGLFKDTLPAWKEKDIQIFVLRIDGNFYDSYQDAMYYLYEKVPVGGLVIFDDVLTHKNVMRFWQDFKNEQKLPEDLNHIDNDATWFRK
D5SXC9_PLAL2/21-290              .DPYIELLKNVLTGAVYEE...SAWRREDGYHRDKFRPLKSLRQFFLKSWAKRGYLVVKAQHFDAKKRELGTDW......P..LFGYSMVGKRRLDQLEVAIRTIAAEQIPGNILEAGVWRGGASMFMKALLNHLGEGHRQLWLADSFEGLPKP...RLAPDT..........K.DKRHDLSECDFL.....KVSIETVSANFERFGLLDENVRFLKGWFCDSLPHANPGKLAL..LRLDGDLYESTMDVLKPLYQNVVPGGFVVVDDYLAWSGCREAIDEFRELHKINAPMFNIDGTGVYWR.
Q2JDH4_FRACC/23-284              SVRYLDLLRATLTCSLWDG...........RDGGAWEPRTGAKRMLVRAFRSQGMEIVKRSAPGA..RTDGRDW......P..RLALTMTGDRRMRNLQECAERVIVDGVPGDFIETGVWRGGACILMRGVLAAYGVPDRTVWVADSFAGLPAPNPGRYAADT..........G.DRHHEYAE...L.....SVSLEQVRDNFRRYGLLDDQVRFLRGWFRDTLPTAPIERLAV..LRLDGDMYESTTDALTALYPKLSDGGFCIVDDYGAVPGCRAAVEDYRAAHGVTEPIIEVDWTCVYWRR
E3IYZ5_FRAIE/13-273              .GRYLDLLRETLTFSLWEG...........RDGRIWRPHRAAHRVLFRLLEARGLELIRYSAVGA..RDVGGDW......P..RLAHTMTGSRRLKQLQEAVEQVLVDDIPGDLIETGVWRGGSAIMMRGVLAAHGVPDRTVWVADSFAGLPAPDPTRWPDDA..........G.DPHHKWSE...L.....VVSETEVRENFRRYGLLDDQVRFLPGWFRDTLPTAPIERLAV..LRLDGDMYESTSEALEALYPRLSDGGFCIIDDYGAVEGCRRAVEDYRNAHQIDDPMIKIDWTGVYWRK
E3I1R4_RHOVT/29-268              RALYIDLLQKTLTNEIYGD.................................LPMDPWSGGKYDATKRALGRDW......P..SQAMTMIGAKRMANLRQLTESVINQGVPGDFIETGVWRGGACVFVRGILKSYGVTDRRVWVADSFEGLPPPDP.NCPQDA..........G.DKHHTWEP...L.....AISQEQVRDNFSKLGLLDDQVKFLKGWFKDTLPGAPIERLAI..LRLDGDMYGSTMDALLPLYAKVSRGGFVIVDDFGAVQGCRQAIADFRAANNITSPIIDIDGVGVFWQ.
Q81GJ3_BACCR/7-280               VQLYLELLKKTILFEIWLEYEAYLPASLHISKELEFEPVTVPLPLFIKQYAENHNLKIVKPNVSKSERHDGMDW......P..RAAHSMIGRERMNQLQEAMETVVRENIEGDFIETGVWRGGSCIFMNGFLQANNITDRNVWVADSFEGLPAPNLEQYPKDY..........G.DYLHTFDY...L.....RVSLEQVQENFKKYDLLNDQVKFLKGWFKDTLPTAPIEKIAI..ARLDGDMYESTMDGLVNLYDKVSKGGYIIIDDYGL.PPCAEAVTDFRNQRNLKAPITKIDVFGVYWRK
#=GC seq_cons                    sphYLDLL+csLssplat-............................p.https.hshptsthstchRtsGtDW......P..shAaTMlGc+RLcpLppsl-sVls-slPGDllETGVWRGGAsIhMRuhLtuaussDRpVWVADSFtGlPsst..thstDt..........G.sthHphsp..hL.....ulS.-pVRcNFccaGLLD-QVRFLcGWFcDTLPsAPl-cLAl..LRLDGDhY-SThDALpsLYs+VSsGGaVIlDDYush.sC+pAVc-aRsspsIssPlhpIDhsuVaWR+
